NIGHTSTAR THERAPEUTICS PLC's ticker is NITE and the CUSIP is 65413A101. A total of 16 filers reported holding NIGHTSTAR THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $430,000 | – | 22,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,785,446 | $28,567,000 | 0.97% |
| Woodford Investment Management Ltd | 314,000 | $5,024,000 | 0.61% |
| NEA Management Company, LLC | 714,285 | $11,429,000 | 0.54% |
| PFM Health Sciences, LP | 1,016,980 | $16,272,000 | 0.26% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 122,074 | $1,953,000 | 0.24% |
| Partner Investment Management, L.P. | 9,523 | $152,000 | 0.12% |
| ASCEND CAPITAL, LLC | 151,691 | $2,428,000 | 0.11% |
| Stanley-Laman Group, Ltd. | 12,181 | $195,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 34,169 | $547,000 | 0.04% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 45,544 | $729,000 | 0.02% |